您的购物车当前为空
JK184 是 Hedgehog 抑制剂,在哺乳动物细胞中的IC50值为 30 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
JK184 是 Hedgehog 抑制剂,在哺乳动物细胞中的IC50值为 30 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 138 | 现货 | |
| 5 mg | ¥ 223 | 现货 | |
| 10 mg | ¥ 371 | 现货 | |
| 25 mg | ¥ 713 | 现货 | |
| 50 mg | ¥ 1,180 | 现货 | |
| 100 mg | ¥ 1,960 | 现货 | |
| 200 mg | ¥ 2,790 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 238 | 现货 |
| 产品描述 | JK184 is a potent Hedgehog (Hh) pathway inhibitor. |
| 靶点活性 | Hedgehog:30 nM |
| 体外活性 | JK184旨在通过剂量依赖性地抑制胶质瘤(Gli)依赖的转录活动,从而拮抗Hh信号。三天孵化后,JK184显著抑制HUVECs的增殖,IC50为6.3 μg/mL。通过在Panc-1和BxPC-3细胞中使用指定浓度的化合物进行MTT试验,测定JK184的半最大抑制浓度(IC50)(在anc-1中为23.7 ng/mL,在BxPC-3中为34.3 ng/mL),以评估JK184的抗肿瘤效果[1]。与MCF10a、MTSV1-7、HMLE-shGFP和HMLE-pBP细胞相比,Claudin-low细胞系对JK184的治疗更敏感,且JK184在这些细胞中引起的胶质瘤相关的致癌基因同源物1(GLI1)转录和蛋白水平的剂量依赖性减少。使用JK184的IC50剂量治疗可以增加HMLE-shEcad细胞染色与Annexin-V阳性但对碘化丙啶(PI)阴性的比例(P<0.0001,t检验)[2]。 |
| 体内活性 | JK184(5 mg/kg,静脉注射)在皮下Panc-1和BxPC-3肿瘤模型中展现了良好的抗增殖活性,并且是针对Hh信号的抗肿瘤化合物的良好候选。组织学分析显示,JK184通过诱导更多的细胞凋亡、降低微血管密度以及减少肿瘤组织中CD31、Ki67和VEGF的表达来增强抗肿瘤活性。然而,JK184的药代动力学特性和生物利用度较差[1]。 |
| 细胞实验 | JK184 is dissolved in DMSO and stored, and then diluted with appropriate medium before use[1]. The Shh-LIGHT2 cells are seeded in 96-well plates and grown to confluency. The Shh-LIGHT2 cells are treated with various concentrations of JK184 micelles or free JK184 or micelles in DMEM containing 0.5% CS, 0.1 mg/mL streptomycin, 100 U/mL penicillin, 5% Shh-N conditioned medium obtained from Shh-N-producing HEK293 cells. The treated cells are cultured further for 60 h, and firefly and Renilla luciferase activities are measured using a dual luciferase kit. Proliferation assay or apoptosis evaluation of HUVECs is measured using MTT method or FCM analysis, respectively. HUVECs are treated with a series concentration of free JK184, JK184 micelles, or blank MPEG-PCL micelles for 48 h, respectively. The mean percentage of cell inhibition or apoptosis is calculated[1]. |
| 分子量 | 350.44 |
| 分子式 | C19H18N4OS |
| CAS No. | 315703-52-7 |
| Smiles | CCOc1ccc(Nc2nc(cs2)-c2c(C)nc3ccccn23)cc1 |
| 密度 | 1.3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 3.51 mg/mL (10.02 mM), Sonication is recommended. | ||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.85 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多